FELBATOL: FELBAMATE ORAL SUSPENSION.
The FELBAMATE ORAL SUSPENSION is a the manufacturer industrial component. Key specifications include special_features: 400 MG;THERAPEUTIC EQUIVALENT TO FELBATOL BY WALLACE LABS;FOR USE AS AN ANTICONVULSANT, primary_container_type: BOTTLE, therapeutic_equivalent: TO FELBATOL BY WALLACE LAB., primary_container_content_quantity: 100.000 TABLETS, part_name_assigned_by_controlling_agency: FELBAMATE TABLETS 400MG 100S BT. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-380-7608, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| special_features | 400 MG;THERAPEUTIC EQUIVALENT TO FELBATOL BY WALLACE LABS;FOR USE AS AN ANTICONVULSANT |
| primary_container_type | BOTTLE |
| therapeutic_equivalent | TO FELBATOL BY WALLACE LAB. |
| primary_container_content_quantity | 100.000 TABLETS |
| part_name_assigned_by_controlling_agency | FELBAMATE TABLETS 400MG 100S BT |
| NSN | 6505-01-380-7608 |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| PRIMARY CONTAINER TYPE | BOTTLE |
| SPECIAL FEATURES | 400 MG;THERAPEUTIC EQUIVALENT TO FELBATOL BY WALLACE LABS;FOR USE AS AN ANTICONVULSANT |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | FELBAMATE TABLETS 400MG 100S BT |